Global Antibody Engineering Services

Antibody Engineering Services Comprehensive Study by Application (Research, Diagnostic, Therapeutics, Others), Services Type (Antibody cDNA Sequencing and Cloning, Humanization, Gene Synthesis, Transient Expression, Isotype Switching, Chimerisation, Others), Antibodies Type (Monoclonal Antibodies, Polyclonal Antibodies, Bispecific Antibodies, Recombinant Antibodies) Players and Region - Global Market Outlook to 2028

Antibody Engineering Services Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Antibody Engineering Services Market Scope
Antibody engineering services are the services involved in modifying the various types of antibodies such as monoclonal antibodies, polyclonal antibodies, bispecific antibodies, recombinant antibodies to enhance or dampen their functions. Antibody engineering services include antibody cDNA sequencing and cloning, humanization, gene synthesis, transient expression, isotype switching, chimerisation, and other services. It is used in research, medical, diagnostics/therapeutics, etc applications. Antibodies are engineered and produced for the treatment of a variety of diseases specifically in cancer therapies.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledPromab Biotechnologies (United States), Creative Biolabs, Inc. (United States), Biologics International Corp (United States), Innovagen AB (Sweden), Abzena Ltd (United Kingdom), YUMAB (Germany), Absolute Antibody (United Kingdom), Fusion Antibodies (United Kingdom), Genscript Biotech (United States) and ExonBIO (United States)
CAGR%


Antibody Engineering Services market is a fragmented market due to the presence of various players. The players are focusing developing innovative products and solutions to improve quality, enhances and promotes performance. The companies are coming up with partnerships or agreements along with planning strategic activities such as partnerships, product launch, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.

Promab Biotechnologies (United States), Creative Biolabs, Inc. (United States), Biologics International Corp (United States), Innovagen AB (Sweden), Abzena Ltd (United Kingdom), YUMAB (Germany), Absolute Antibody (United Kingdom), Fusion Antibodies (United Kingdom), Genscript Biotech (United States) and ExonBIO (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are LakePharma (United States), Amgen Inc. (United States), Sino Biological (China), GenScrip (United States) and WuXi Biologics (China).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Antibody Engineering Services market by Type , by Application (Research, Diagnostic, Therapeutics and Others) and Region with country level break-up.

On the basis of geography, the market of Antibody Engineering Services has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies

In April 2020, Adaptive Extends Immune Medicine Platform to Discover Therapeutic Antibodies from Recovered COVID-19 Patients and Amgen Will Leverage Genetics, Immunology, Antibody Engineering, and Manufacturing Capabilities Companies Will Begin Work Immediately. The mutually exclusive collaboration brings together Adaptive's proprietary immune medicine platform for the identification of virus-neutralizing antibodies with Amgen's expertise in immunology and novel antibody therapy development. Given the rapidly rising incidence of COVID-19 around the world, the companies will begin work immediately and finalize financial details and terms in the coming weeks.


Influencing Trend:
Rising Drug Discovery Activities By Many Healthcare and Research Institutes and Advancement in Biotechnology Industry

Market Growth Drivers:
Growing Cancer and Autoimmune Diseases in People and Need for Diagnostics and Therapeutic Solutions for Chronic Disease

Challenges:
Stiff Competition in the Antibody Engineering Services Market

Restraints:
Regulatory Guidelines and Compliance Involved in Antibody Engineering Services

Opportunities:
Surging Investment and Spendings on the Medical and LifeSciences Operations will Boost the Antibody Engineering Services Market

Key Target Audience
Antibody Engineering Services Providers, Antibody Engineering Services Industry Associations, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others

Report Objectives / Segmentation Covered

By Application
  • Research
  • Diagnostic
  • Therapeutics
  • Others
By Services Type
  • Antibody cDNA Sequencing and Cloning
  • Humanization
  • Gene Synthesis
  • Transient Expression
  • Isotype Switching
  • Chimerisation
  • Others

By Antibodies Type
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Bispecific Antibodies
  • Recombinant Antibodies

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Cancer and Autoimmune Diseases in People
      • 3.2.2. Need for Diagnostics and Therapeutic Solutions for Chronic Disease
    • 3.3. Market Challenges
      • 3.3.1. Stiff Competition in the Antibody Engineering Services Market
    • 3.4. Market Trends
      • 3.4.1. Rising Drug Discovery Activities By Many Healthcare and Research Institutes
      • 3.4.2. Advancement in Biotechnology Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antibody Engineering Services, by Application, Services Type, Antibodies Type and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Antibody Engineering Services (Value)
      • 5.2.1. Global Antibody Engineering Services by: Application (Value)
        • 5.2.1.1. Research
        • 5.2.1.2. Diagnostic
        • 5.2.1.3. Therapeutics
        • 5.2.1.4. Others
      • 5.2.2. Global Antibody Engineering Services by: Services Type (Value)
        • 5.2.2.1. Antibody cDNA Sequencing and Cloning
        • 5.2.2.2. Humanization
        • 5.2.2.3. Gene Synthesis
        • 5.2.2.4. Transient Expression
        • 5.2.2.5. Isotype Switching
        • 5.2.2.6. Chimerisation
        • 5.2.2.7. Others
      • 5.2.3. Global Antibody Engineering Services by: Antibodies Type (Value)
        • 5.2.3.1. Monoclonal Antibodies
        • 5.2.3.2. Polyclonal Antibodies
        • 5.2.3.3. Bispecific Antibodies
        • 5.2.3.4. Recombinant Antibodies
      • 5.2.4. Global Antibody Engineering Services Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Antibody Engineering Services (Price)
  • 6. Antibody Engineering Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Promab Biotechnologies (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Creative Biolabs, Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biologics International Corp (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Innovagen AB (Sweden)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abzena Ltd (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. YUMAB (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Absolute Antibody (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Fusion Antibodies (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Genscript Biotech (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ExonBIO (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Antibody Engineering Services Sale, by Application, Services Type, Antibodies Type and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Antibody Engineering Services (Value)
      • 7.2.1. Global Antibody Engineering Services by: Application (Value)
        • 7.2.1.1. Research
        • 7.2.1.2. Diagnostic
        • 7.2.1.3. Therapeutics
        • 7.2.1.4. Others
      • 7.2.2. Global Antibody Engineering Services by: Services Type (Value)
        • 7.2.2.1. Antibody cDNA Sequencing and Cloning
        • 7.2.2.2. Humanization
        • 7.2.2.3. Gene Synthesis
        • 7.2.2.4. Transient Expression
        • 7.2.2.5. Isotype Switching
        • 7.2.2.6. Chimerisation
        • 7.2.2.7. Others
      • 7.2.3. Global Antibody Engineering Services by: Antibodies Type (Value)
        • 7.2.3.1. Monoclonal Antibodies
        • 7.2.3.2. Polyclonal Antibodies
        • 7.2.3.3. Bispecific Antibodies
        • 7.2.3.4. Recombinant Antibodies
      • 7.2.4. Global Antibody Engineering Services Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Antibody Engineering Services (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antibody Engineering Services: by Application(USD Million)
  • Table 2. Antibody Engineering Services Research , by Region USD Million (2017-2022)
  • Table 3. Antibody Engineering Services Diagnostic , by Region USD Million (2017-2022)
  • Table 4. Antibody Engineering Services Therapeutics , by Region USD Million (2017-2022)
  • Table 5. Antibody Engineering Services Others , by Region USD Million (2017-2022)
  • Table 6. Antibody Engineering Services: by Services Type(USD Million)
  • Table 7. Antibody Engineering Services Antibody cDNA Sequencing and Cloning , by Region USD Million (2017-2022)
  • Table 8. Antibody Engineering Services Humanization , by Region USD Million (2017-2022)
  • Table 9. Antibody Engineering Services Gene Synthesis , by Region USD Million (2017-2022)
  • Table 10. Antibody Engineering Services Transient Expression , by Region USD Million (2017-2022)
  • Table 11. Antibody Engineering Services Isotype Switching , by Region USD Million (2017-2022)
  • Table 12. Antibody Engineering Services Chimerisation , by Region USD Million (2017-2022)
  • Table 13. Antibody Engineering Services Others , by Region USD Million (2017-2022)
  • Table 14. Antibody Engineering Services: by Antibodies Type(USD Million)
  • Table 15. Antibody Engineering Services Monoclonal Antibodies , by Region USD Million (2017-2022)
  • Table 16. Antibody Engineering Services Polyclonal Antibodies , by Region USD Million (2017-2022)
  • Table 17. Antibody Engineering Services Bispecific Antibodies , by Region USD Million (2017-2022)
  • Table 18. Antibody Engineering Services Recombinant Antibodies , by Region USD Million (2017-2022)
  • Table 19. South America Antibody Engineering Services, by Country USD Million (2017-2022)
  • Table 20. South America Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 21. South America Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 22. South America Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 23. Brazil Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 24. Brazil Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 25. Brazil Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 26. Argentina Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 27. Argentina Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 28. Argentina Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 29. Rest of South America Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 30. Rest of South America Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 31. Rest of South America Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 32. Asia Pacific Antibody Engineering Services, by Country USD Million (2017-2022)
  • Table 33. Asia Pacific Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 34. Asia Pacific Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 35. Asia Pacific Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 36. China Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 37. China Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 38. China Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 39. Japan Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 40. Japan Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 41. Japan Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 42. India Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 43. India Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 44. India Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 45. South Korea Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 46. South Korea Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 47. South Korea Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 48. Taiwan Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 49. Taiwan Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 50. Taiwan Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 51. Australia Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 52. Australia Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 53. Australia Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 54. Rest of Asia-Pacific Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 55. Rest of Asia-Pacific Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 56. Rest of Asia-Pacific Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 57. Europe Antibody Engineering Services, by Country USD Million (2017-2022)
  • Table 58. Europe Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 59. Europe Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 60. Europe Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 61. Germany Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 62. Germany Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 63. Germany Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 64. France Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 65. France Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 66. France Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 67. Italy Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 68. Italy Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 69. Italy Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 70. United Kingdom Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 71. United Kingdom Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 72. United Kingdom Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 73. Netherlands Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 74. Netherlands Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 75. Netherlands Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 76. Rest of Europe Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 77. Rest of Europe Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 78. Rest of Europe Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 79. MEA Antibody Engineering Services, by Country USD Million (2017-2022)
  • Table 80. MEA Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 81. MEA Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 82. MEA Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 83. Middle East Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 84. Middle East Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 85. Middle East Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 86. Africa Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 87. Africa Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 88. Africa Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 89. North America Antibody Engineering Services, by Country USD Million (2017-2022)
  • Table 90. North America Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 91. North America Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 92. North America Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 93. United States Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 94. United States Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 95. United States Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 96. Canada Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 97. Canada Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 98. Canada Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 99. Mexico Antibody Engineering Services, by Application USD Million (2017-2022)
  • Table 100. Mexico Antibody Engineering Services, by Services Type USD Million (2017-2022)
  • Table 101. Mexico Antibody Engineering Services, by Antibodies Type USD Million (2017-2022)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Antibody Engineering Services: by Application(USD Million)
  • Table 113. Antibody Engineering Services Research , by Region USD Million (2023-2028)
  • Table 114. Antibody Engineering Services Diagnostic , by Region USD Million (2023-2028)
  • Table 115. Antibody Engineering Services Therapeutics , by Region USD Million (2023-2028)
  • Table 116. Antibody Engineering Services Others , by Region USD Million (2023-2028)
  • Table 117. Antibody Engineering Services: by Services Type(USD Million)
  • Table 118. Antibody Engineering Services Antibody cDNA Sequencing and Cloning , by Region USD Million (2023-2028)
  • Table 119. Antibody Engineering Services Humanization , by Region USD Million (2023-2028)
  • Table 120. Antibody Engineering Services Gene Synthesis , by Region USD Million (2023-2028)
  • Table 121. Antibody Engineering Services Transient Expression , by Region USD Million (2023-2028)
  • Table 122. Antibody Engineering Services Isotype Switching , by Region USD Million (2023-2028)
  • Table 123. Antibody Engineering Services Chimerisation , by Region USD Million (2023-2028)
  • Table 124. Antibody Engineering Services Others , by Region USD Million (2023-2028)
  • Table 125. Antibody Engineering Services: by Antibodies Type(USD Million)
  • Table 126. Antibody Engineering Services Monoclonal Antibodies , by Region USD Million (2023-2028)
  • Table 127. Antibody Engineering Services Polyclonal Antibodies , by Region USD Million (2023-2028)
  • Table 128. Antibody Engineering Services Bispecific Antibodies , by Region USD Million (2023-2028)
  • Table 129. Antibody Engineering Services Recombinant Antibodies , by Region USD Million (2023-2028)
  • Table 130. South America Antibody Engineering Services, by Country USD Million (2023-2028)
  • Table 131. South America Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 132. South America Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 133. South America Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 134. Brazil Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 135. Brazil Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 136. Brazil Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 137. Argentina Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 138. Argentina Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 139. Argentina Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 140. Rest of South America Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 141. Rest of South America Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 142. Rest of South America Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 143. Asia Pacific Antibody Engineering Services, by Country USD Million (2023-2028)
  • Table 144. Asia Pacific Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 145. Asia Pacific Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 146. Asia Pacific Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 147. China Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 148. China Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 149. China Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 150. Japan Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 151. Japan Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 152. Japan Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 153. India Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 154. India Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 155. India Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 156. South Korea Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 157. South Korea Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 158. South Korea Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 159. Taiwan Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 160. Taiwan Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 161. Taiwan Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 162. Australia Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 163. Australia Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 164. Australia Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 165. Rest of Asia-Pacific Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 166. Rest of Asia-Pacific Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 167. Rest of Asia-Pacific Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 168. Europe Antibody Engineering Services, by Country USD Million (2023-2028)
  • Table 169. Europe Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 170. Europe Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 171. Europe Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 172. Germany Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 173. Germany Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 174. Germany Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 175. France Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 176. France Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 177. France Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 178. Italy Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 179. Italy Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 180. Italy Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 181. United Kingdom Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 182. United Kingdom Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 183. United Kingdom Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 184. Netherlands Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 185. Netherlands Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 186. Netherlands Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 187. Rest of Europe Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 188. Rest of Europe Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 189. Rest of Europe Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 190. MEA Antibody Engineering Services, by Country USD Million (2023-2028)
  • Table 191. MEA Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 192. MEA Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 193. MEA Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 194. Middle East Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 195. Middle East Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 196. Middle East Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 197. Africa Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 198. Africa Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 199. Africa Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 200. North America Antibody Engineering Services, by Country USD Million (2023-2028)
  • Table 201. North America Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 202. North America Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 203. North America Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 204. United States Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 205. United States Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 206. United States Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 207. Canada Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 208. Canada Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 209. Canada Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 210. Mexico Antibody Engineering Services, by Application USD Million (2023-2028)
  • Table 211. Mexico Antibody Engineering Services, by Services Type USD Million (2023-2028)
  • Table 212. Mexico Antibody Engineering Services, by Antibodies Type USD Million (2023-2028)
  • Table 213. Research Programs/Design for This Report
  • Table 214. Key Data Information from Secondary Sources
  • Table 215. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antibody Engineering Services: by Application USD Million (2017-2022)
  • Figure 5. Global Antibody Engineering Services: by Services Type USD Million (2017-2022)
  • Figure 6. Global Antibody Engineering Services: by Antibodies Type USD Million (2017-2022)
  • Figure 7. South America Antibody Engineering Services Share (%), by Country
  • Figure 8. Asia Pacific Antibody Engineering Services Share (%), by Country
  • Figure 9. Europe Antibody Engineering Services Share (%), by Country
  • Figure 10. MEA Antibody Engineering Services Share (%), by Country
  • Figure 11. North America Antibody Engineering Services Share (%), by Country
  • Figure 12. Global Antibody Engineering Services share by Players 2022 (%)
  • Figure 13. Global Antibody Engineering Services share by Players (Top 3) 2022(%)
  • Figure 14. Global Antibody Engineering Services share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Promab Biotechnologies (United States) Revenue, Net Income and Gross profit
  • Figure 17. Promab Biotechnologies (United States) Revenue: by Geography 2022
  • Figure 18. Creative Biolabs, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Creative Biolabs, Inc. (United States) Revenue: by Geography 2022
  • Figure 20. Biologics International Corp (United States) Revenue, Net Income and Gross profit
  • Figure 21. Biologics International Corp (United States) Revenue: by Geography 2022
  • Figure 22. Innovagen AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 23. Innovagen AB (Sweden) Revenue: by Geography 2022
  • Figure 24. Abzena Ltd (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. Abzena Ltd (United Kingdom) Revenue: by Geography 2022
  • Figure 26. YUMAB (Germany) Revenue, Net Income and Gross profit
  • Figure 27. YUMAB (Germany) Revenue: by Geography 2022
  • Figure 28. Absolute Antibody (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Absolute Antibody (United Kingdom) Revenue: by Geography 2022
  • Figure 30. Fusion Antibodies (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 31. Fusion Antibodies (United Kingdom) Revenue: by Geography 2022
  • Figure 32. Genscript Biotech (United States) Revenue, Net Income and Gross profit
  • Figure 33. Genscript Biotech (United States) Revenue: by Geography 2022
  • Figure 34. ExonBIO (United States) Revenue, Net Income and Gross profit
  • Figure 35. ExonBIO (United States) Revenue: by Geography 2022
  • Figure 36. Global Antibody Engineering Services: by Application USD Million (2023-2028)
  • Figure 37. Global Antibody Engineering Services: by Services Type USD Million (2023-2028)
  • Figure 38. Global Antibody Engineering Services: by Antibodies Type USD Million (2023-2028)
  • Figure 39. South America Antibody Engineering Services Share (%), by Country
  • Figure 40. Asia Pacific Antibody Engineering Services Share (%), by Country
  • Figure 41. Europe Antibody Engineering Services Share (%), by Country
  • Figure 42. MEA Antibody Engineering Services Share (%), by Country
  • Figure 43. North America Antibody Engineering Services Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Promab Biotechnologies (United States)
  • Creative Biolabs, Inc. (United States)
  • Biologics International Corp (United States)
  • Innovagen AB (Sweden)
  • Abzena Ltd (United Kingdom)
  • YUMAB (Germany)
  • Absolute Antibody (United Kingdom)
  • Fusion Antibodies (United Kingdom)
  • Genscript Biotech (United States)
  • ExonBIO (United States)
Additional players considered in the study are as follows:
LakePharma (United States) , Amgen Inc. (United States) , Sino Biological (China) , GenScrip (United States) , WuXi Biologics (China)
Select User Access Type

Key Highlights of Report


May 2023 205 Pages 59 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antibody Engineering Services Quantitative research analysis
Global Antibody Engineering Services Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Antibody Engineering Services Market are by end use application [Research, Diagnostic, Therapeutics and Others].
The Antibody Engineering Services Market is gaining popularity and expected to see strong valuation by 2028.
  • Growing Cancer and Autoimmune Diseases in People
  • Need for Diagnostics and Therapeutic Solutions for Chronic Disease

Know More About Global Antibody Engineering Services Report?

Have a Query? Click Here

Other Related Reports

Atomic Force Microscopes Comprehensive Study by Type (Contact AFM, Non-contact AFM, Dynamic contact AFM, Tapping AFM), Application (Material Science, Life Sciences, Semiconductors and Electronics, Ac...
$ 3350
Electrophoresis Comprehensive Study by Type (Electrophoresis Reagents, Gel Electrophoresis Systems, Capillary Electrophoresis Systems, Gel Documentation Systems, Software), Application (Diagnostic, R...
$ 3750
Phospholipase Comprehensive Study by Type (Phospholipase A, Phospholipase B, Phospholipase C, Phospholipase D), Application (Food and Beverages, Bakery Products, Medicines, Others), Industry Vertical...
$ 3450
Pharmaceutical Analytical Testing Outsourcing Comprehensive Study by Application (Genotoxic Impurities, Leachables & Extractables, Elemental Impurities, Others), Services (Bioanalytical Testing, Meth...
$ 3750
Obesity Management Comprehensive Study by Type (Drug, Surgery), Application (Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Retail Pharmacies), Equipment Type (Fitness Equipment, Fitness...
$ 3650
Mycotoxin Testing Comprehensive Study by Application (Feed, Food), Food tested (Nuts, Spices, Grains, Seed, Processed foods, Dairy products, Meat, Pulses, Cereals, Others), Technology (Chromatography...
$ 3650